<?xml version="1.0" encoding="UTF-8"?>
<p>RSV fusion protein inhibitors (FPI) have shown somewhat better results in animal models. FPI decreased clinical scores, viral shedding, and histology using the same bovine RSV infection model described here. However, these effects were markedly attenuated when treatment was started on day 3 compared with day 1 post-inoculation. [16]</p>
